PDF herunterladen
Am J Perinatol 2019; 36(09): 891-897
DOI: 10.1055/s-0039-1678733
SMFM Fellowship Series Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Real-Time Continuous Glucose Monitoring in Gestational Diabetes: A Randomized Controlled Trial

Andrew S. Lane
1   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia
,
Malgorzata A. Mlynarczyk
1   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia
,
Margarita de Veciana
1   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia
,
Lauren M. Green
2   Healthcare Analytics and Delivery Science Institute, Eastern Virginia Medical School, Norfolk, Virginia
,
Dana I. Baraki
3   Eastern Virginia Medical School, Norfolk, Virginia
,
Alfred Z. Abuhamad
1   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia
› Institutsangaben Funding Medtronic (Northridge, CA) provided investigator-initiated research support for this project through a scientific research grant (MDT ID# NERP17–006). The grant allowed for discounted pricing on medical devices used in this study. Medtronic had no part in the design, execution, or analysis of this project, or on the composition or editing of this manuscript. Medtronic has reviewed the manuscript prior to submission to ensure the correct nomenclature of its products. All authors have adhered to the Good Publication Practice (GPP3) for manuscripts that are supported by medical device companies.
Weitere Informationen

Publikationsverlauf

11. Januar 2019

11. Januar 2019

Publikationsdatum:
28. Februar 2019 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Objective To evaluate whether real-time continuous glucose monitoring improves glycemic control over intermittent self-monitoring of blood glucose in gestational diabetes.

Study Design We performed a single-institution randomized controlled trial. Patients with gestational diabetes were randomized to use either real-time or blinded continuous glucose monitoring. The primary outcome was mean sensor glucose level during the fourth week of continuous glucose monitoring use. Secondary outcomes included glycemic control and a composite of obstetric and neonatal outcomes.

Results Of the 40 enrolled patients, 12 (60%) patients in the blinded continuous glucose monitoring group and 11 (55%) in the real-time continuous glucose monitoring group completed 4 weeks of monitoring and were included in the final analysis. There was no significant difference in mean sensor glucose level between the blinded continuous glucose monitoring group (98.9 ± 8.9 mg/dL) and the real-time continuous glucose monitoring group (107.5 ± 11.4 mg/dL). There were also no significant differences in the time spent in glycemic target, maternal, or neonatal outcomes.

Conclusion Our study shows that the use of continuous glucose monitoring with real-time feedback did not significantly decrease mean glucose values compared with intermittent self-monitoring of blood glucose after 4 weeks of continuous glucose monitoring use.

Keywords

gestational diabetes - diabetes - pregnancy - continuous glucose monitoring - glucose monitoring

Clinical Trials Registry

ClinicalTrials.gov #NCT03326232. Date of registration: October 31, 2017. Date of initial enrollment: December 1, 2017. Available at https://clinicaltrials.gov/ct2/show/NCT03326232?cond=continuous+glucose+monitoring+in+gestational+diabetes&rank=2.


Note

The findings of this study have been presented as an oral presentation at the 39th annual Society for Maternal–Fetal Pregnancy Medicine meeting, February 11–16, 2019, in Las Vegas, Nevada.


Kommentar zu diesem Artikel:

SMFM 2020: Manuscript of the Year—Interview with Dr. Andrew S. Lane (Podcast)Am J Perinatol 2020; 37(S 01): e1-e1
DOI: 10.1055/s-0040-1705268

 

  • References

  • 1 Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 190: gestational diabetes mellitus. Obstet Gynecol 2018; 131 (02) e49-e64
    CrossrefPubMedGoogle Scholar
  • 2 Correa A, Bardenheier B, Elixhauser A, Geiss LS, Gregg E. Trends in prevalence of diabetes among delivery hospitalizations, United States, 1993-2009. Matern Child Health J 2015; 19 (03) 635-642
    CrossrefPubMedGoogle Scholar
  • 3 Wier LM, Burgess J, Elixhauser A. Hospitalizations Related to Diabetes in Pregnancy, 2008: Statistical Brief #102. Rockville, MD: Agency for Healthcare Research and Quality; 2010
    Google Scholar
  • 4 Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. ; Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352 (24) 2477-2486
    CrossrefPubMedGoogle Scholar
  • 5 Landon MB, Spong CY, Thom E. , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009; 361 (14) 1339-1348
    CrossrefPubMedGoogle Scholar
  • 6 Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Donovan L. Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research. Ann Intern Med 2013; 159 (02) 123-129
    CrossrefPubMedGoogle Scholar
  • 7 Professional Practice Committee. Professional Practice Committee: Standards of Medical Care in Diabetes-2018 . Diabetes Care 2018; 41 (Suppl. 01) S3
    CrossrefPubMedGoogle Scholar
  • 8 Murphy HR, Rayman G, Lewis K. , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ 2008; 337: a1680
    CrossrefPubMedGoogle Scholar
  • 9 Kestilä KK, Ekblad UU, Rönnemaa T. Continuous glucose monitoring versus self-monitoring of blood glucose in the treatment of gestational diabetes mellitus. Diabetes Res Clin Pract 2007; 77 (02) 174-179
    CrossrefPubMedGoogle Scholar
  • 10 Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144 (07) 768-773
    CrossrefPubMedGoogle Scholar
  • 11 Yu F, Lv L, Liang Z. , et al. Continuous glucose monitoring effects on maternal glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus: a prospective cohort study. J Clin Endocrinol Metab 2014; 99 (12) 4674-4682
    CrossrefPubMedGoogle Scholar
  • 12 Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42 (02) 377-381
    CrossrefPubMedGoogle Scholar
  • 13 Głowińska-Olszewska B, Tobiaszewska M, Łuczyński W, Bossowski A. Monthly use of a real-time continuous glucose monitoring system as an educational and motivational tool for poorly controlled type 1 diabetes adolescents. Adv Med Sci 2013; 58 (02) 344-352
    CrossrefPubMedGoogle Scholar
  • 14 Yoo HJ, An HG, Park SY. , et al. Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes. Diabetes Res Clin Pract 2008; 82 (01) 73-79
    CrossrefPubMedGoogle Scholar
  • 15 Yogev Y, Ben-Haroush A, Chen R, Kaplan B, Phillip M, Hod M. Continuous glucose monitoring for treatment adjustment in diabetic pregnancies--a pilot study. Diabet Med 2003; 20 (07) 558-562
    CrossrefPubMedGoogle Scholar
  • 16 Porter H, Lookinland S, Belfort MA. Evaluation of a new real-time blood continuous glucose monitoring system in pregnant women without gestational diabetes. A pilot study. J Perinat Neonatal Nurs 2004; 18 (02) 93-102
    CrossrefPubMedGoogle Scholar
  • 17 McLachlan K, Jenkins A, O'Neal D. The role of continuous glucose monitoring in clinical decision-making in diabetes in pregnancy. Aust N Z J Obstet Gynaecol 2007; 47 (03) 186-190
    CrossrefPubMedGoogle Scholar
  • 18 Alfadhli E, Osman E, Basri T. Use of a real time continuous glucose monitoring system as an educational tool for patients with gestational diabetes. Diabetol Metab Syndr 2016; 8: 48
    CrossrefPubMedGoogle Scholar
  • 19 Kamann S, Aerts O, Heinemann L. Further evidence of severe allergic contact dermatitis from isobornyl acrylate while using a continuous glucose monitoring system. J Diabetes Sci Technol 2018; 12 (03) 630-633
    CrossrefPubMedGoogle Scholar
  • 20 Adolfsson P, Parkin CG, Thomas A, Krinelke LG. Selecting the appropriate continuous glucose monitoring system - a practical approach. Eur Endocrinol 2018; 14 (01) 24-29
    PubMedGoogle Scholar
  • 21 Miremberg H, Ben-Ari T, Betzer T. , et al. The impact of a daily smartphone-based feedback system among women with gestational diabetes on compliance, glycemic control, satisfaction, and pregnancy outcome: a randomized controlled trial. Am J Obstet Gynecol 2018; 218 (04) 453.e1-453.e7
    CrossrefPubMedGoogle Scholar